New York, NY (PRWEB via PRWebDirect) September 13, 2006 -- TriMark Publications (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Avian Influenza report. The purpose of this report is to describe the threatening world pandemic caused by avian influenza, also known as bird flu. This analysis discusses the origins of the disease, the bird-to-human infection risks, the catastrophic health crisis avian flu poses, and the efforts by world governments and international health organizations to mitigate the impact of the threat to humans.
Influenza, commonly known as the flu, is an infectious disease that infects birds and mammals (primarily of the upper airways and lungs in mammals) and is caused by an RNA virus. Flu rapidly spreads around the world in seasonal epidemics, killing millions of people in pandemic years and hundreds of thousands in non-pandemic years. Three influenza pandemics in the 20th century—each following a major genetic change in the virus—killed millions of people all over the world. The world’s current major influenza pandemic threat is H5N1, but it is at present mostly in birds not in people. The specific objectives of this analysis are to:
•
Examine the epidemiology of avian influenza.
•
Describe the diagnosis and treatments available for influenza.
•
Discuss preparedness for a worldwide pandemic.
•
Evaluate the world economic impact of an influenza epidemic.
The goal is to review the potential threat of a human influenza pandemic resulting from the avian flu virus and define the responses that are now being undertaken worldwide by governmental authorities to contain the spreading bird flu. Specifically, this study contains:
•
A comprehensive overview of the several categories of anti-influenza technology platforms that are or will be revolutionizing flu related healthcare in hospitals.
•
Full descriptions of the public health measures involved in controlling the spread of avian influenza and the prevention of cross infection to humans.
•
Analysis of the technological approaches undertaken by various world governments, as well as industry and end-user response to these ideas.
•
Regulatory issues and legislation affecting use and marketing of influenza prevention and treatment products.
•
Forecasts for each category of infection control.
This analysis will allow the reader to:
•
Evaluate the effect of strategic factors and technology driven measures for controlling avian flu and subsequent human infections.
•
Investigate how cost-constraints and technological advances are driving change in the influenza market.
•
Examine the structure of the avian flu response across the world and learn how to respond successfully to this challenge to human health.
•
Assess the growth opportunities in all influenza-related treatments and preventative measures.
•
Review the main approaches in each sector and plan a strategy in line with the strengths and weaknesses of the infection control measures.
Reasons to Buy TriMark Content
•
Content is updated regularly in accordance with changes in the industries our reports cover.
•
Content is specifically designed to help individuals who work in the industries the content covers remain competitive in the marketplace.
•
Content contains detailed sales data, market share information and emerging trends, all of which impact the sectors biotechnology, healthcare, pharmaceutical and medical devices companies operate in.
•
Your competitors are buying TriMark content!
About TriMark Publications, LLC
Based in New York City, TriMark Publications is a global leader in the biotechnology, healthcare and life sciences publishing. Market research reports include:
•
Avian Influenza
•
Bioinformatics Markets
•
Blood Gas Instrumentation Data Processing
•
Blood Glucose Testing and Diabetes Management
•
Cancer Diagnostic Testing World Markets
•
Cancer Therapeutics Markets
•
Cardiac Marker Diagnostic Tests Markets
•
Cardiac Rhythm Management Devices World Markets
•
Cytology and HPV Testing World Markets
•
Clinical Chemistry Analyzers
•
Diabetes, Metabolic Syndrome and Cardiovascular Disease
•
Disposable Medical Supplies Markets
•
Disposable Syringe Markets
•
DNA Sequencing and PCR Markets
•
Genomics World Markets
•
High-Growth Diagnostic Tests Markets
•
Indian Pharmaceutical Industry
•
Key Diagnostic Testing Markets
•
Mammography World Markets
•
Microarray Markets
•
Microscopy Markets
•
Molecular Diagnostics Markets
•
Multi-Parameter Patient Monitor Markets
•
Nutraceuticals and Dietary Supplements Markets
•
Over-the-Counter Diagnostic Products Markets
•
Pharmacogenomic Testing Markets
•
Point of Care Diagnostic Testing World Markets
•
RNA Interference Markets
•
Veterinary Health Markets
•
Women's Health: Diagnostic Tests
For more information, please visit http://www.trimarkpublications.com.
Important Notice
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
Contact
TriMark Publications, LLC
212.265.9877
www.trimarkpublications.com
# # #
|
